Esker Therapeutics Funding & Investors
South San Francisco, CA
Esker is a precision medicines company looking to eliminate the “all-comers” approach that is seen with today’s treatments for people with autoimmune disease. Even with the innovation of the last decade, many patients continue to cycle through the approved therapies while continuing to look for the right therapy to alleviate the impact of their disease without life-impacting side effects. Esker leverages a precision analytics platform, powered by Foresite Labs, coupled with a team of experts with deep experience in precision medicine drug development and immunology, in order to create medicines that change the lives of people with autoimmune disease.
eskertx.comTotal Amount Raised: $529,000,000
Esker Therapeutics Funding Rounds
Series C
$259,000,000
Series C Investors
Foresite CapitalSamsara BioCapitalvenBio PartnersSr OneLilly Asia VenturesCormorant Asset ManagementMatrix Capital ManagementABGOmega FundsPiper Heartland Healthcare CapitalHBM Healthcare InvestmentsNextechSeries B
$200,000,000
Series B Investors
Matrix Capital ManagementSeries A
$70,000,000
Series A Investors
Foresite Capital
Funding info provided by Diffbot.